Definitive Healthcare (NASDAQ:DH) Issues Quarterly Earnings Results, Beats Estimates By $0.02 EPS

Definitive Healthcare (NASDAQ:DH) posted its quarterly earnings results on Thursday. The company reported $0.06 earnings per share for the quarter, beating the consensus estimate of $0.04 by $0.02, FiscalAI reports. Definitive Healthcare had a negative net margin of 69.18% and a positive return on equity of 4.07%. The company had revenue of $54.65 million during the quarter, compared to analyst estimates of $54.58 million.

Definitive Healthcare Stock Performance

DH traded up $0.02 during trading hours on Friday, hitting $1.15. The stock had a trading volume of 324,402 shares, compared to its average volume of 394,086. The company’s fifty day simple moving average is $1.02 and its 200 day simple moving average is $1.06. Definitive Healthcare has a 1 year low of $0.61 and a 1 year high of $3.00. The stock has a market cap of $122.76 million, a PE ratio of 28.75, a price-to-earnings-growth ratio of 14.19 and a beta of 1.40. The company has a quick ratio of 1.86, a current ratio of 1.86 and a debt-to-equity ratio of 0.81.

Analyst Ratings Changes

A number of research firms have weighed in on DH. Morgan Stanley dropped their target price on shares of Definitive Healthcare from $2.50 to $1.50 and set an “equal weight” rating on the stock in a research note on Tuesday, August 11th. Weiss Ratings upgraded shares of Definitive Healthcare from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday. BTIG Research restated a “neutral” rating on shares of Definitive Healthcare in a research note on Friday, September 4th. Wall Street Zen raised shares of Definitive Healthcare from a “hold” rating to a “buy” rating in a report on Sunday, September 13th. Finally, Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and issued a $1.00 price objective on shares of Definitive Healthcare in a research note on Wednesday, August 12th. Six research analysts have rated the stock with a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat.com, the company has an average rating of “Reduce” and a consensus price target of $1.47.

About Definitive Healthcare

Definitive Healthcare Corp. (NASDAQ: DH) provides data, analytics and commercial intelligence solutions for the healthcare industry. Its platform is designed to help organizations understand healthcare markets, identify business opportunities and make data-driven decisions.

The company serves pharmaceutical and biotechnology companies, medical device manufacturers, healthcare providers, hospitals and health systems, and other healthcare services organizations. Its offerings include information on healthcare providers and organizations, market intelligence, sales and marketing analytics, clinical trial insights, and tools that support commercial planning, market access and customer engagement.

Definitive Healthcare was founded in 2011 and became a publicly traded company in 2021.